GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
2 535,00 ₹
arrow_upward
+1,63%(+40,70) 1D
2 նոյ, 15:30:00 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
2 494,30 ₹
High
2 583,10 ₹
Low
2 494,30 ₹
Mkt. cap
428,43 մլրդ
Avg. vol.
63,41 հզր
Volume
67,15 հզր
Dividend
2,25%
Quarterly dividend
14,25 ₹
Ex-dividend date
29 մյս, 2026 թ.
P/E ratio
40,20
52-wk high
3 120,70 ₹
52-wk low
2 088,10 ₹
EPS
63,05 ₹
Shares outstanding
169,41 մլն
No. of employees
3 հզր
Open
2 494,30 ₹
High
2 583,10 ₹
Low
2 494,30 ₹
Mkt. cap
428,43 մլրդ
Avg. vol.
63,41 հզր
Volume
67,15 հզր
Dividend
2,25%
Quarterly dividend
14,25 ₹
Ex-dividend date
29 մյս, 2026 թ.
P/E ratio
40,20
52-wk high
3 120,70 ₹
52-wk low
2 088,10 ₹
EPS
63,05 ₹
Shares outstanding
169,41 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
Seeking Alpha
·
2 ժամ առաջ
S&P 500 Quant Leaders: 5 Top Stocks Ready For A Rally
RealMoney Pro
·
10 րոպե առաջ
Tech’s Monday Bounce Reverses, Pushing the Nasdaq-100 into Correction
Quantisnow
·
9 րոպե առաջ
XMAX
Bloomberg.com
·
1 ժամ առաջ
Nasdaq Slide Clouds Asian Open, Oil Holds Losses: Markets Wrap
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd